List of Tables
Table 1. Global Acyclovir Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Acyclovir Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Acyclovir Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Acyclovir Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Acyclovir Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Acyclovir Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Acyclovir Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Acyclovir Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Acyclovir Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Acyclovir Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Acyclovir Drug, Product Type & Application
Table 12. Global Key Manufacturers of Acyclovir Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Acyclovir Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acyclovir Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Acyclovir Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Acyclovir Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Acyclovir Drug Sales Market Share by Region (2020-2025)
Table 19. Global Acyclovir Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Acyclovir Drug Sales Market Share by Region (2026-2031)
Table 21. Global Acyclovir Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Acyclovir Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Acyclovir Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Acyclovir Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Acyclovir Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Acyclovir Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Acyclovir Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Acyclovir Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Acyclovir Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Acyclovir Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Acyclovir Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Acyclovir Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Acyclovir Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Acyclovir Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Acyclovir Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Acyclovir Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Acyclovir Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Acyclovir Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Acyclovir Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Acyclovir Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Acyclovir Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Acyclovir Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Acyclovir Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Acyclovir Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Acyclovir Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Acyclovir Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Acyclovir Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Acyclovir Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Acyclovir Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Acyclovir Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Acyclovir Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Acyclovir Drug Sales Market Share by Type (2020-2025)
Table 53. Global Acyclovir Drug Sales Market Share by Type (2026-2031)
Table 54. Global Acyclovir Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Acyclovir Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Acyclovir Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Acyclovir Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Acyclovir Drug Price (USD/Unit) by Type (2020-2025)
Table 59. Global Acyclovir Drug Price (USD/Unit) by Type (2026-2031)
Table 60. Global Acyclovir Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Acyclovir Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Acyclovir Drug Sales Market Share by Application (2020-2025)
Table 63. Global Acyclovir Drug Sales Market Share by Application (2026-2031)
Table 64. Global Acyclovir Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Acyclovir Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Acyclovir Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Acyclovir Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Acyclovir Drug Price (USD/Unit) by Application (2020-2025)
Table 69. Global Acyclovir Drug Price (USD/Unit) by Application (2026-2031)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. GSK Acyclovir Drug Product
Table 74. GSK Recent Developments/Updates
Table 75. Zydus Pharmaceuticals Company Information
Table 76. Zydus Pharmaceuticals Description and Business Overview
Table 77. Zydus Pharmaceuticals Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Zydus Pharmaceuticals Acyclovir Drug Product
Table 79. Zydus Pharmaceuticals Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Mylan Acyclovir Drug Product
Table 84. Mylan Recent Developments/Updates
Table 85. Bausch Health Company Information
Table 86. Bausch Health Description and Business Overview
Table 87. Bausch Health Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bausch Health Acyclovir Drug Product
Table 89. Bausch Health Recent Developments/Updates
Table 90. Vectans Pharma Company Information
Table 91. Vectans Pharma Description and Business Overview
Table 92. Vectans Pharma Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Vectans Pharma Acyclovir Drug Product
Table 94. Vectans Pharma Recent Developments/Updates
Table 95. Fresenius Kabi Company Information
Table 96. Fresenius Kabi Description and Business Overview
Table 97. Fresenius Kabi Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Fresenius Kabi Acyclovir Drug Product
Table 99. Fresenius Kabi Recent Developments/Updates
Table 100. Aurobindo Pharma Company Information
Table 101. Aurobindo Pharma Description and Business Overview
Table 102. Aurobindo Pharma Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Aurobindo Pharma Acyclovir Drug Product
Table 104. Aurobindo Pharma Recent Developments/Updates
Table 105. Teva Company Information
Table 106. Teva Description and Business Overview
Table 107. Teva Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Teva Acyclovir Drug Product
Table 109. Teva Recent Developments/Updates
Table 110. Heritage Pharmaceuticals Company Information
Table 111. Heritage Pharmaceuticals Description and Business Overview
Table 112. Heritage Pharmaceuticals Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Heritage Pharmaceuticals Acyclovir Drug Product
Table 114. Heritage Pharmaceuticals Recent Developments/Updates
Table 115. APOTEX Company Information
Table 116. APOTEX Description and Business Overview
Table 117. APOTEX Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. APOTEX Acyclovir Drug Product
Table 119. APOTEX Recent Developments/Updates
Table 120. Cadila Pharmaceuticals Company Information
Table 121. Cadila Pharmaceuticals Description and Business Overview
Table 122. Cadila Pharmaceuticals Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Cadila Pharmaceuticals Acyclovir Drug Product
Table 124. Cadila Pharmaceuticals Recent Developments/Updates
Table 125. Amneal Pharmaceuticals Company Information
Table 126. Amneal Pharmaceuticals Description and Business Overview
Table 127. Amneal Pharmaceuticals Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Amneal Pharmaceuticals Acyclovir Drug Product
Table 129. Amneal Pharmaceuticals Recent Developments/Updates
Table 130. TARO Company Information
Table 131. TARO Description and Business Overview
Table 132. TARO Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. TARO Acyclovir Drug Product
Table 134. TARO Recent Developments/Updates
Table 135. Glenmark Company Information
Table 136. Glenmark Description and Business Overview
Table 137. Glenmark Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Glenmark Acyclovir Drug Product
Table 139. Glenmark Recent Developments/Updates
Table 140. G&W Laboratories Company Information
Table 141. G&W Laboratories Description and Business Overview
Table 142. G&W Laboratories Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. G&W Laboratories Acyclovir Drug Product
Table 144. G&W Laboratories Recent Developments/Updates
Table 145. Yiling Pharmaceutical Ltd Company Information
Table 146. Yiling Pharmaceutical Ltd Description and Business Overview
Table 147. Yiling Pharmaceutical Ltd Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Yiling Pharmaceutical Ltd Acyclovir Drug Product
Table 149. Yiling Pharmaceutical Ltd Recent Developments/Updates
Table 150. Alembic Pharmaceuticals Company Information
Table 151. Alembic Pharmaceuticals Description and Business Overview
Table 152. Alembic Pharmaceuticals Acyclovir Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Alembic Pharmaceuticals Acyclovir Drug Product
Table 154. Alembic Pharmaceuticals Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Acyclovir Drug Distributors List
Table 158. Acyclovir Drug Customers List
Table 159. Acyclovir Drug Market Trends
Table 160. Acyclovir Drug Market Drivers
Table 161. Acyclovir Drug Market Challenges
Table 162. Acyclovir Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Acyclovir Drug
Figure 2. Global Acyclovir Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Acyclovir Drug Market Share by Type: 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Topical Product Picture
Figure 6. Injection Product Picture
Figure 7. Global Acyclovir Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Acyclovir Drug Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Drug Store
Figure 11. Global Acyclovir Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Acyclovir Drug Market Size (2020-2031) & (US$ Million)
Figure 13. Global Acyclovir Drug Sales (2020-2031) & (K Units)
Figure 14. Global Acyclovir Drug Average Price (USD/Unit) & (2020-2031)
Figure 15. Acyclovir Drug Report Years Considered
Figure 16. Acyclovir Drug Sales Share by Manufacturers in 2024
Figure 17. Global Acyclovir Drug Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Acyclovir Drug Players: Market Share by Revenue in Acyclovir Drug in 2024
Figure 19. Acyclovir Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Acyclovir Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Acyclovir Drug Sales Market Share by Country (2020-2031)
Figure 22. North America Acyclovir Drug Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Acyclovir Drug Sales Market Share by Country (2020-2031)
Figure 26. Europe Acyclovir Drug Revenue Market Share by Country (2020-2031)
Figure 27. Germany Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Acyclovir Drug Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Acyclovir Drug Revenue Market Share by Region (2020-2031)
Figure 34. China Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Acyclovir Drug Sales Market Share by Country (2020-2031)
Figure 45. Latin America Acyclovir Drug Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Acyclovir Drug Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Acyclovir Drug Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Acyclovir Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Acyclovir Drug by Type (2020-2031)
Figure 55. Global Revenue Market Share of Acyclovir Drug by Type (2020-2031)
Figure 56. Global Acyclovir Drug Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Acyclovir Drug by Application (2020-2031)
Figure 58. Global Revenue Market Share of Acyclovir Drug by Application (2020-2031)
Figure 59. Global Acyclovir Drug Price (USD/Unit) by Application (2020-2031)
Figure 60. Acyclovir Drug Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
